Journal of Genetic Syndromes & Gene Therapy

Journal of Genetic Syndromes & Gene Therapy
Open Access

ISSN: ISSN: 2157-7412

+32-2-808-70-17

Citations Report

Citations Report - Journal of Genetic Syndromes & Gene Therapy [186 Articles]

The articles published in Journal of Genetic Syndromes & Gene Therapy have been cited 186 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Journal of Genetic Syndromes & Gene Therapy.

Di Gioia S, Trapani A, Castellani S, Carbone A, Belgiovine G, et al. (2015) Nanocomplexes for gene therapy of respiratory diseases: targeting and overcoming the mucus barrier. Pulmonary pharmacology & therapeutics 34: 8-24.

Sarkar D, Perrin GQ, Zolotukhin S, Srivastava A, Herzog RW (2013) Gene Therapists Determined to Stop the Bleeding!. Journal of Genetic Syndromes & Gene Therapy 1:1.

Herzog RW, Daniell H (2014), inventors; The Trustees Of The University Of Pennsylvania, University Of Florida Research Foundation, Inc., assignee. Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients. United States patent application US 15/037,045.

Fellmann C, Gowen BG, Lin PC, Doudna JA, Corn JE (2016) Cornerstones of CRISPR-Cas in drug discovery and therapy. Nature Reviews Drug Discovery.

Factor VI. Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells.

Mao J, Xi X, Kapranov P, Dong B, Firrman J, et al. (2013) In vitro and In vivo Model Systems for Hemophilia A Gene Therapy. Journal of genetic syndromes & gene therapy.

Sherman A, Su J, Lin S, Wang X, Herzog RW, ët al (2014). Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood 124: 1659-68.

Sahin U, Karikó K, Türeci Ö (2014) mRNA-based therapeutics—developing a new class of drugs. Nature reviews Drug discovery 13: 759-80.

Matrai J, Chuah M, Vandendriessche T (2012) Advances and future perspectives in lentiviral gene therapy for hemophilia A and B. Journal of Genetic Syndromes and Gene Therapy 1.

de Sousa Bomfim A, de Freitas MC, Picanço-Castro V, Neto MD, Swiech K, et al. (2016) Human cell lines: A promising alternative for recombinant FIX production. Protein expression and purification 121: 149-56.

Sarkar D, Perrin GQ, Zolotukhin S, Srivastava A, Herzog RW (2013) Gene Therapists Determined to Stop the Bleeding!. Journal of Genetic Syndromes & Gene Therapy 1:1.

Herzog RW, Daniell H (2014) inventors; The Trustees Of The University Of Pennsylvania, University Of Florida Research Foundation, Inc., assignee. Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients. United States patent application US 15/037,045.

Kumar L, Varghese R, Menon RN, Siddharthan N (2015) Perioperative management of a patient with severe Haemophilia B for abdominal pseudotumour Surgery. Indian journal of anaesthesia 59: 461.

Marlina D, Reniarti L, Veronica F (2017) Five-Year Data of Clinical Characteristics and Laboratory Findings of Hospitalized Hemophilic Patients in Dr. Hasan Sadikin General Hospital. Althea Medical Journal 3: 605-9.

Factor VI. Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells.

Sherman A, Su J, Lin S, Wang X, Herzog RW, et al. (2014) Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood 124: 1659-68.

AlAbdulkareem I, Abdi S, AIFawaz M, AlBalwi M (2011) LMX1B gene mutation in a Saudi patient with bilateral symmetrical hypoplastic nails of the hands. J Genet Syndr Gene Ther 2.

Zakas PM, Spencer HT, Doering CB (2011). Engineered hematopoietic stem cells as therapeutics for hemophilia A. Journal of genetic syndromes & gene therapy 1.

Greene TK, Lambert MP, Poncz M (2011). Ectopic platelet-delivered factor (F) VIII for the treatment of Hemophilia A: Plasma and platelet FVIII, is it all the same?. Journal of genetic syndromes & gene therapy 12.

Vilaboa N, Boellmann F, Voellmy R (2011) Gene switches for deliberate regulation of transgene expression: recent advances in system development and uses. J Genet Syndr Gene Ther 2: 2.

Top